E Soularue
Overview
Explore the profile of E Soularue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
850
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al.
Ann Oncol
. 2019 Aug;
30(12):2012.
PMID: 31408090
No abstract available.
2.
Collins M, Michot J, Danlos F, Mussini C, Soularue E, Mateus C, et al.
Ann Oncol
. 2017 Oct;
28(11):2860-2865.
PMID: 29045560
Background: Immune check-point blockade agents have shown clinical activity in cancer patients but are associated with immune-related adverse events that could limit their development. The aim of this study was...
3.
Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al.
Ann Oncol
. 2017 Apr;
28(6):1368-1379.
PMID: 28368458
Background: Ipilimumab, an immune checkpoint inhibitor targeting CTLA-4, prolongs survival in a subset of patients with metastatic melanoma (MM) but can induce immune-related adverse events, including enterocolitis. We hypothesized that...
4.
Marthey L, Mateus C, Mussini C, Nachury M, Nancey S, Grange F, et al.
J Crohns Colitis
. 2016 Jan;
10(4):395-401.
PMID: 26783344
Background: Therapeutic monoclonal anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibodies are associated with immune-mediated enterocolitis. The aim of this study was to provide a detailed description of this entity. Methods: We...